Comment on 'Suicide in prison in the North of Italy (1993-2022): a case control study examining differences between suicides inside and outside prison' [0.03%]
对“意大利北部（1993-2022年）监狱自杀案：一项病例对照研究，考察监狱内外自杀的差异”的评论
José L Rodríguez-Hernández,Alvaro J Idrovo
José L Rodríguez-Hernández
Focus on mood disorders, obsessive-compulsive disorders, and prisoners' treatments [0.03%]
情绪障碍、强迫症和服刑人员的治疗研究:focus on mood disorders, obsessive-compulsive disorders, and prisoners' treatments
Alessandro Serretti
Alessandro Serretti
Assessing treatment adherence in psychiatry: a comparison of clinical judgment and therapeutic drug monitoring in acute care [0.03%]
精神疾病治疗顺应性的评估：临床判断与治疗性药物监测的对比研究（以急性期病人作为对象）
Giorgio Pigato,Nicola Meda,Marco Paladin et al.
Giorgio Pigato et al.
Treatment adherence is the cornerstone of the management of psychiatric disorders in the prevention of acute symptom exacerbation, relapse, and hospitalization. Patients are usually treated with psychotropic polypharmacy, including complex ...
Impact of selected second and third generation antipsychotics on cognitive dysfunction in schizophrenia-spectrum disorders. Systematic review and network meta-analysis [0.03%]
第二代和第三代抗精神病药物对精神分裂症患者认知功能障碍的影响-系统评价和网络meta分析
Paolo Olgiati,Antonino Messina,Vincenzo Oliva et al.
Paolo Olgiati et al.
Cognitive dysfunction is a core feature of schizophrenia spectrum disorders and a major determinant of functional outcomes. This study aimed to: (a) systematically review randomized controlled trials (RCTs) evaluating the cognitive effects ...
Comparing adherence and persistence of common selective serotonin reuptake inhibitors in veterans with major depressive disorder: a retrospective analysis of Veterans Affairs healthcare data [0.03%]
退伍军人重大抑郁障碍选择性血清素再摄取抑制剂坚持度和依从性的比较：退伍军人健康管理局医疗数据的回顾性分析
Ryan D Pittman
Ryan D Pittman
Depression has a high prevalence and increasing incidence in the USA. Antidepressants, particularly selective serotonin reuptake inhibitors (SSRIs), are the most commonly used treatments. To be effective, SSRIs must be taken consistently. T...
Suicide behind bars: time to tackle barriers to mental healthcare access in prisons [0.03%]
监狱中的自杀问题：是时候解决囚犯获得精神卫生服务的障碍了
Yasin Hasan Balcioglu
Yasin Hasan Balcioglu
An algorithmic approach to the case management of patients diagnosed with schizophrenia and substance use disorders: what is the evidence? [0.03%]
精神分裂症和物质使用障碍患者的病例管理的算法方法有哪些证据？
Octavian Vasiliu
Octavian Vasiliu
Lumateperone monotherapy for major depressive episodes associated with bipolar disorder: efficacy and safety in a randomized placebo-controlled trial [0.03%]
用于治疗与双相情感障碍相关的重度抑郁发作的单用 lumateperone：一项随机、安慰剂对照试验中的有效性和安全性研究
Christoph U Correll,Suresh Durgam,Susan G Kozauer et al.
Christoph U Correll et al.
This Phase 3, randomized, double-blind, placebo-controlled study evaluated the efficacy and safety of lumateperone to treat bipolar depression. Patients (18-75 years) with bipolar I or bipolar II disorder experiencing a major depressive epi...